Chemistry:Prolintane
From HandWiki
Short description: Stimulant and NDRI drug
|  | |
|  | |
| Clinical data | |
|---|---|
| Routes of administration | oral, intranasal, rectal | 
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C15H23N | 
| Molar mass | 217.356 g·mol−1 | 
| 3D model (JSmol) | |
| Melting point | 133 °C (271 °F) | 
| Boiling point | 153 °C (307 °F) | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant[1] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[2] Being an amphetamine derivative, it is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[3] Many cases of prolintane abuse have been reported.[4]
Under the trade-name "Katovit", prolintane was commercialized by the Spanish pharmaceutical company, FHER. Katovit was sold until 2001, and was most often used by students and workers as a stimulant to provide energy, promote alertness and concentration.
See also
- α-PVP (β-ketone-prolintane, prolintanone)
- Methylenedioxypyrovalerone (MDPV)
- Pyrovalerone (Centroton, Thymergix)
- Phenylpropylaminopentane
References
- ↑ "A new stimulant, prolintane hydrochloride, compared with dextroamphetamine in fatigued volunteers". The Journal of Clinical Pharmacology and the Journal of New Drugs 10 (2): 103–9. March–April 1970. doi:10.1177/009127007001000205. PMID 4392006.
- ↑ GB Patent 807835
- ↑ "Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline". British Journal of Clinical Pharmacology 10 (5): 465–72. November 1980. doi:10.1111/j.1365-2125.1980.tb01790.x. PMID 7437258.
- ↑ "Domestic abuse of the European rave drug prolintane". Journal of Analytical Toxicology 31 (7): 415–8. September 2007. doi:10.1093/jat/31.7.415. PMID 17725890.
|  | 


